Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,145 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and efficacy of the tumor-selective adenovirus enadenotucirev, in combination with nivolumab, in patients with advanced/metastatic epithelial cancer: a phase I clinical trial (SPICE).
Fakih M, Harb W, Mahadevan D, Babiker H, Berlin J, Lillie T, Krige D, Carter J, Cox C, Patel M, Parfitt L, Powell M, Rosen L. Fakih M, et al. Among authors: powell m. J Immunother Cancer. 2023 Apr;11(4):e006561. doi: 10.1136/jitc-2022-006561. J Immunother Cancer. 2023. PMID: 37094988 Free PMC article. Clinical Trial.
Phase II trial of bortezomib plus doxorubicin in hepatocellular carcinoma (E6202): a trial of the Eastern Cooperative Oncology Group.
Ciombor KK, Feng Y, Benson AB 3rd, Su Y, Horton L, Short SP, Kauh JS, Staley C, Mulcahy M, Powell M, Amiri KI, Richmond A, Berlin J. Ciombor KK, et al. Among authors: powell m. Invest New Drugs. 2014 Oct;32(5):1017-27. doi: 10.1007/s10637-014-0111-8. Epub 2014 Jun 4. Invest New Drugs. 2014. PMID: 24890858 Free PMC article. Clinical Trial.
ARCTIC: durvalumab with or without tremelimumab as third-line or later treatment of metastatic non-small-cell lung cancer.
Planchard D, Reinmuth N, Orlov S, Fischer JR, Sugawara S, Mandziuk S, Marquez-Medina D, Novello S, Takeda Y, Soo R, Park K, McCleod M, Geater SL, Powell M, May R, Scheuring U, Stockman P, Kowalski D. Planchard D, et al. Among authors: powell m. Ann Oncol. 2020 May;31(5):609-618. doi: 10.1016/j.annonc.2020.02.006. Epub 2020 Feb 20. Ann Oncol. 2020. PMID: 32201234 Free article. Clinical Trial.
Genetic variation in DNA-repair pathways and response to radiochemotherapy in esophageal adenocarcinoma: a retrospective cohort study of the Eastern Cooperative Oncology Group.
Yoon HH, Catalano PJ, Murphy KM, Skaar TC, Philips S, Powell M, Montgomery EA, Hafez MJ, Offer SM, Liu G, Meltzer SJ, Wu X, Forastiere AA, Benson AB, Kleinberg LR, Gibson MK. Yoon HH, et al. Among authors: powell m. BMC Cancer. 2011 May 17;11:176. doi: 10.1186/1471-2407-11-176. BMC Cancer. 2011. PMID: 21586140 Free PMC article.
Genetic variation in radiation and platinum pathways predicts severe acute radiation toxicity in patients with esophageal adenocarcinoma treated with cisplatin-based preoperative radiochemotherapy: results from the Eastern Cooperative Oncology Group.
Yoon HH, Catalano P, Gibson MK, Skaar TC, Philips S, Montgomery EA, Hafez MJ, Powell M, Liu G, Forastiere AA, Benson AB, Kleinberg LR, Murphy KM. Yoon HH, et al. Among authors: powell m. Cancer Chemother Pharmacol. 2011 Oct;68(4):863-70. doi: 10.1007/s00280-011-1556-5. Epub 2011 Feb 1. Cancer Chemother Pharmacol. 2011. PMID: 21286719 Free PMC article. Clinical Trial.
The doctor will polygraph you now.
Anibal J, Gunkel J, Awan S, Huth H, Nguyen H, Le T, Bélisle-Pipon JC, Boyer M, Hazen L; Bridge2AI Voice Consortium; Bensoussan Y, Clifton D, Wood B. Anibal J, et al. Npj Health Syst. 2024;1(1):1. doi: 10.1038/s44401-024-00001-4. Epub 2024 Dec 5. Npj Health Syst. 2024. PMID: 39759269 Free PMC article.
Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of Chemoradiation Versus Chemotherapy for Locally Advanced Endometrial Carcinoma.
Matei DE, Enserro DM, Randall ME, Mutch D, Small W, DiSilvestro PA, Spirtos NM, O'Malley DM, Cantuaria GH, Michelin D, Waggoner S, Shahin M, Guntupalli S, Lara O, Ueland FR, Warshal D, Bonebrake A, Tewari KS, Tan A, Powell MA, Walker JL, Santin AD, Kim JH, Miller DS. Matei DE, et al. Among authors: powell ma. J Clin Oncol. 2024 Dec 19:JCO2401121. doi: 10.1200/JCO.24.01121. Online ahead of print. J Clin Oncol. 2024. PMID: 39700442
Summary of Keynote Speeches from the 2024 Voice AI Symposium, presented by the Bridge2AI-Voice Consortium.
Patel R, Price N, Bahr R, Bedrick S, Bensoussan Y, Bélisle-Pipon JC, Dorr D, Jackson C, Krussel A, Salvi Cruz S, Toghranegar J, Watts S, Zhao R; Bridge2AI-Voice Consortium; Powell M. Patel R, et al. Among authors: powell m. Front Digit Health. 2024 Dec 3;6:1484503. doi: 10.3389/fdgth.2024.1484503. eCollection 2024. Front Digit Health. 2024. PMID: 39691415 Free PMC article. Review.
2,145 results